{
  "id": "e7d86094a9980564",
  "title": "Johnson & Johnson submits application to the European Medicines Agency for TECVAYLI\u00ae\u25bc ( teclistamab ) in combination with DARZALEX\u00ae ( daratumumab ) subcut",
  "description": "20260106T160000Z",
  "content": "",
  "source": "pharmiweb.com",
  "source_url": "https://www.pharmiweb.com/press-release/2026-01-06/johnson-johnson-submits-application-to-the-european-medicines-agency-for-tecvayli-teclistamab-in-combination-with-darzalex-daratumumab-subcut",
  "published_at": "20260106T160000Z",
  "fetched_at": "2026-01-07T00:22:40.638561+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.pharmiweb.com/press-release/2026-01-06/johnson-johnson-submits-application-to-the-european-medicines-agency-for-tecvayli-teclistamab-in-combination-with-darzalex-daratumumab-subcut",
    "url_mobile": "",
    "title": "Johnson & Johnson submits application to the European Medicines Agency for TECVAYLI\u00ae\u25bc ( teclistamab ) in combination with DARZALEX\u00ae ( daratumumab ) subcut",
    "seendate": "20260106T160000Z",
    "socialimage": "https://cdn.pharmiweb.com/media/1024/1200x448-pwjobs.png",
    "domain": "pharmiweb.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}